Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Mix

Showing results (21-30 of 111) with videos related to

Pageof 12
Sort By:
Lung Cancer (Auckland, N.Z.)|November 23, 2018
Clinical outcomes following advanced respiratory motion management (respiratory gating or dynamic tumor tracking) with stereotactic body radiation therapy for stage I non-small-cell lung cancerPaul Aridgides, Tamara Nsouli, Rishabh Chaudhari, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 16, 2004
Can body volume be determined by PET?Michael Hentschel, Dominik Paul, Ulrike Korsten-Reck, et al.
Urology Case Reports|March 10, 2016
Stereotactic Body Radiotherapy for the Treatment of Renal TumorsMichael Hanzly, Terrance Creighton, Michael Mix, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 16, 2013
Exploratory geographical analysis of hypoxic subvolumes using 18F-MISO-PET imaging in patients with head and neck cancer in the course of primary chemoradiotherapyMartin-Immanuel Bittner, Nicole Wiedenmann, Sabine Bucher, et al.
Annals of Nuclear Medicine|December 5, 2025
Prognostic value of whole-body tumor SUV dispersion on baseline PSMA PET prior to PSMA radioligand therapyFelix Kind, Ursula Nemer, Katia Brüggemann, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 12, 2025
Divergent effects of age on imaging-based ATN biomarkers and cognition in Alzheimer's diseaseLars Frings, Sabine Hellwig, Joachim Brumberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 25, 2013
Hybrid imaging of peripheral skeletal disease by SPECT/high-resolution flat-panel CTChristian Lohrmann, Oliver Hauschild, Philipp T Meyer, et al.
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|October 1, 2003
3D-Cardiac-PET. A Recommendable Clinical Alternative to 2D-Cardiac-PET?Ingo Brink, Thilmann Schumacher, Jochen Talazko, et al.
World Journal of Clinical Oncology|October 16, 2015
Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neckMichael Mix, Anurag K Singh, Michael Tills, et al.
EJNMMI Research|June 14, 2020
Voxel-based comparison of [<sup>68</sup>Ga]Ga-RM2-PET/CT and [<sup>68</sup>Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancerThomas Franz Fassbender, Florian Schiller, Constantinos Zamboglou, et al.
Pageof 12

Showing results (21-30 of 111) with videos related to

Sort By:
Pageof 12
Lung Cancer (Auckland, N.Z.)|November 23, 2018
Clinical outcomes following advanced respiratory motion management (respiratory gating or dynamic tumor tracking) with stereotactic body radiation therapy for stage I non-small-cell lung cancerPaul Aridgides, Tamara Nsouli, Rishabh Chaudhari, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 16, 2004
Can body volume be determined by PET?Michael Hentschel, Dominik Paul, Ulrike Korsten-Reck, et al.
Urology Case Reports|March 10, 2016
Stereotactic Body Radiotherapy for the Treatment of Renal TumorsMichael Hanzly, Terrance Creighton, Michael Mix, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 16, 2013
Exploratory geographical analysis of hypoxic subvolumes using 18F-MISO-PET imaging in patients with head and neck cancer in the course of primary chemoradiotherapyMartin-Immanuel Bittner, Nicole Wiedenmann, Sabine Bucher, et al.
Annals of Nuclear Medicine|December 5, 2025
Prognostic value of whole-body tumor SUV dispersion on baseline PSMA PET prior to PSMA radioligand therapyFelix Kind, Ursula Nemer, Katia Brüggemann, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 12, 2025
Divergent effects of age on imaging-based ATN biomarkers and cognition in Alzheimer's diseaseLars Frings, Sabine Hellwig, Joachim Brumberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 25, 2013
Hybrid imaging of peripheral skeletal disease by SPECT/high-resolution flat-panel CTChristian Lohrmann, Oliver Hauschild, Philipp T Meyer, et al.
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|October 1, 2003
3D-Cardiac-PET. A Recommendable Clinical Alternative to 2D-Cardiac-PET?Ingo Brink, Thilmann Schumacher, Jochen Talazko, et al.
World Journal of Clinical Oncology|October 16, 2015
Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neckMichael Mix, Anurag K Singh, Michael Tills, et al.
EJNMMI Research|June 14, 2020
Voxel-based comparison of [<sup>68</sup>Ga]Ga-RM2-PET/CT and [<sup>68</sup>Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancerThomas Franz Fassbender, Florian Schiller, Constantinos Zamboglou, et al.
Pageof 12